Pharmacy Times articleshttps://www.pharmacytimes.com/newsPharmacy Times articles© 2026 MJH Life Sciences™ and Pharmacy Times. All rights reserved.Thu, 08 Oct 2026 07:14:37 +00005en-us14447https://www.pharmacytimes.com/newshttps://www.pharmacytimes.com/logo.webphttps://www.pharmacytimes.com/view/intensive-bp-control-cuts-cv-risk-regardless-of-ckd-statushttps://www.pharmacytimes.com/view/intensive-bp-control-cuts-cv-risk-regardless-of-ckd-status<![CDATA[A meta-analysis of 27 trials found 15% lower cardiovascular (CV) event risk per 10-mm Hg SBP reduction, with eGFR declines but no rise in kidney failure.]]>Wed, 07 Oct 2026 20:50:09 GMTPharmacy TimesusPharmacy Times Articleshttps://www.pharmacytimes.com/view/could-car-t-cells-be-reprogrammed-after-infusion-to-target-cancer-again-https://www.pharmacytimes.com/view/could-car-t-cells-be-reprogrammed-after-infusion-to-target-cancer-again-<![CDATA[In an interview with Pharmacy Times, City of Hope researchers discuss a preclinical platform designed to redirect CAR T cells after infusion and how pharmacists could help bring this adaptable approach into clinical practice.]]>Wed, 07 Oct 2026 19:16:57 GMTPharmacy TimesusPharmacy Times Articleshttps://www.pharmacytimes.com/view/fat-and-cholesterol-myths-pharmacists-should-addresshttps://www.pharmacytimes.com/view/fat-and-cholesterol-myths-pharmacists-should-address<![CDATA[From red meat to 'big and fluffy' LDL, a lipid expert unpacks fat and cholesterol misconceptions that persist among patients and clinicians.]]>Wed, 07 Oct 2026 18:00:00 GMTPharmacy TimesusPharmacy Times Articleshttps://www.pharmacytimes.com/view/mavacamten-in-adolescents-with-ohcm-what-pharmacists-should-knowhttps://www.pharmacytimes.com/view/mavacamten-in-adolescents-with-ohcm-what-pharmacists-should-know<![CDATA[Pharmacists play a large role in mavacamten care, screening for interacting drugs that can raise exposure and may require dose adjustment or withholding. ]]>Wed, 07 Oct 2026 16:30:00 GMTPharmacy TimesusPharmacy Times Articleshttps://www.pharmacytimes.com/view/linvoseltamab-in-smoldering-myeloma-fewer-doses-less-risk-https://www.pharmacytimes.com/view/linvoseltamab-in-smoldering-myeloma-fewer-doses-less-risk-<![CDATA[In an interview with Pharmacy Times, Paula Rodríguez-Otero, MD, PhD, discusses less frequent linvoseltamab dosing, CRS monitoring, and how community practices could prepare for its potential use in high-risk smoldering multiple myeloma.]]>Wed, 07 Oct 2026 16:14:34 GMTPharmacy TimesusPharmacy Times Articleshttps://www.pharmacytimes.com/view/when-parents-decline-the-vitamin-k-shot-what-every-pharmacist-needs-to-knowhttps://www.pharmacytimes.com/view/when-parents-decline-the-vitamin-k-shot-what-every-pharmacist-needs-to-know<![CDATA[Pharmacists can explain the evidence supporting the intramuscular injection, address specific concerns, and help families understand what is known—and what is not known—about oral vitamin K.]]>Wed, 07 Oct 2026 16:00:00 GMTPharmacy TimesusPharmacy Times Articleshttps://www.pharmacytimes.com/view/the-mid-career-money-decisions-that-matter-mosthttps://www.pharmacytimes.com/view/the-mid-career-money-decisions-that-matter-most<![CDATA[As earning years peak, so do spending and responsibility—here’s where midcareer pharmacists should focus their financial decision-making.]]>Wed, 07 Oct 2026 14:38:30 GMTPharmacy TimesusPharmacy Times Articleshttps://www.pharmacytimes.com/view/lenacapavir-for-hiv-treatment-vs-prevention-avoiding-pharmacy-dispensing-errorshttps://www.pharmacytimes.com/view/lenacapavir-for-hiv-treatment-vs-prevention-avoiding-pharmacy-dispensing-errors<![CDATA[One molecule now carries both a prevention and a treatment indication, and the panel outlines how pharmacists serve as the critical checkpoint against dispensing errors and inadvertent monotherapy.]]>Wed, 07 Oct 2026 12:05:00 GMTPharmacy TimesusPharmacy Times Articleshttps://www.pharmacytimes.com/view/beyond-viral-suppression-holistic-hiv-care-and-remaining-treatment-gapshttps://www.pharmacytimes.com/view/beyond-viral-suppression-holistic-hiv-care-and-remaining-treatment-gaps<![CDATA[As people with HIV live longer, first-line decisions increasingly hinge on cardiovascular risk, comorbidities, and drug interactions — areas where the pharmacist's full view of the medication list matters most.]]>Wed, 07 Oct 2026 12:00:00 GMTPharmacy TimesusPharmacy Times Articleshttps://www.pharmacytimes.com/view/reframing-statins-and-brain-health-around-stroke-preventionhttps://www.pharmacytimes.com/view/reframing-statins-and-brain-health-around-stroke-prevention<![CDATA[Validating patient concerns, then reframing around stroke prevention, can help pharmacists counsel patients who worry that statins harm memory. ]]>Tue, 06 Oct 2026 20:33:00 GMTPharmacy TimesusPharmacy Times Articleshttps://www.pharmacytimes.com/view/phase-3-trial-finds-adding-monoclonal-antibody-to-mrna-vaccine-improves-covid-19-immunization-tolerabilityhttps://www.pharmacytimes.com/view/phase-3-trial-finds-adding-monoclonal-antibody-to-mrna-vaccine-improves-covid-19-immunization-tolerability<![CDATA[Michael Mina, MD, PhD, discusses phase 3 LIBERTY study data showing that the monoclonal antibody VYD2311, alone or combined with an mRNA COVID-19 vaccine, was associated with fewer adverse events than vaccination alone.]]>Tue, 06 Oct 2026 20:13:46 GMTPharmacy TimesusPharmacy Times Articleshttps://www.pharmacytimes.com/view/petrelintide-yields-up-to-10-7-weight-loss-with-mild-gi-effectshttps://www.pharmacytimes.com/view/petrelintide-yields-up-to-10-7-weight-loss-with-mild-gi-effects<![CDATA[In the phase 2 ZUPREME 1 trial, the once-weekly amylin analog was well tolerated, with nausea mostly mild and limited to dose escalation.]]>Tue, 06 Oct 2026 19:00:00 GMTPharmacy TimesusPharmacy Times Articleshttps://www.pharmacytimes.com/view/semaglutide-normalized-liver-fat-in-most-adults-with-obesityhttps://www.pharmacytimes.com/view/semaglutide-normalized-liver-fat-in-most-adults-with-obesity<![CDATA[Post hoc STEP UP data at EASD 2026 show liver fat fell from 8.8% to 3.1% at 72 weeks in a 55-person MRI subgroup, though no placebo comparison was reported.]]>Tue, 06 Oct 2026 16:51:09 GMTPharmacy TimesusPharmacy Times Articleshttps://www.pharmacytimes.com/view/linvoseltamab-in-smoldering-myeloma-is-early-treatment-worth-the-risk-https://www.pharmacytimes.com/view/linvoseltamab-in-smoldering-myeloma-is-early-treatment-worth-the-risk-<![CDATA[In an interview with Pharmacy Times, Paula Rodríguez-Otero, MD, PhD, discusses patient selection for LINKER-SMM1 and weighs the potential benefits of early linvoseltamab treatment against infection risk in high-risk smoldering multiple myeloma.]]>Tue, 06 Oct 2026 16:48:40 GMTPharmacy TimesusPharmacy Times Articleshttps://www.pharmacytimes.com/view/mrna-re-enters-the-mainstreamhttps://www.pharmacytimes.com/view/mrna-re-enters-the-mainstream<![CDATA[Despite the controversy surrounding mRNA's role in the COVID-19 response, the technology's broader promise—to prevent, treat, and even cure a host of diseases—is coming into focus.]]>Tue, 06 Oct 2026 15:44:31 GMTPharmacy TimesusPharmacy Times Articleshttps://www.pharmacytimes.com/view/expert-q-a-pharmacist-outlines-influenza-vaccine-selection-and-timing-considerations-for-2026-2027https://www.pharmacytimes.com/view/expert-q-a-pharmacist-outlines-influenza-vaccine-selection-and-timing-considerations-for-2026-2027<![CDATA[Age is the leading factor in influenza vaccine selection, and vaccination remains effective well beyond the ideal September-to-October window.]]>Tue, 06 Oct 2026 15:01:07 GMTPharmacy TimesusPharmacy Times Articleshttps://www.pharmacytimes.com/view/how-pharmacists-can-correct-statin-misconceptions-at-pickuphttps://www.pharmacytimes.com/view/how-pharmacists-can-correct-statin-misconceptions-at-pickup<![CDATA[Alexander Turchin, MD, MS, recommends shared decision-making, time-limited lifestyle trials, and gentle persistence to move patients toward statins. ]]>Tue, 06 Oct 2026 14:00:00 GMTPharmacy TimesusPharmacy Times Articleshttps://www.pharmacytimes.com/view/why-patients-fear-statins-will-affect-their-memoryhttps://www.pharmacytimes.com/view/why-patients-fear-statins-will-affect-their-memory<![CDATA[A lipidologist traces patient fears to 2012 FDA label language and reviews observational and randomized data showing no cognitive harm from statins. ]]>Mon, 05 Oct 2026 20:33:58 GMTPharmacy TimesusPharmacy Times Articleshttps://www.pharmacytimes.com/view/pharmacy-technician-day-reflecting-on-the-10-year-evolution-of-the-pharmacy-technicianhttps://www.pharmacytimes.com/view/pharmacy-technician-day-reflecting-on-the-10-year-evolution-of-the-pharmacy-technician<![CDATA[As Pharmacy Technician Day approaches, the CEO of the Pharmacy Technician Certification Board argues that real recognition means career ladders, consistent scope regulations, and investment in certification.]]>Mon, 05 Oct 2026 20:31:57 GMTPharmacy TimesusPharmacy Times Articleshttps://www.pharmacytimes.com/view/suzetrigine-after-knee-replacement-are-fewer-opioid-prescriptions-enough-https://www.pharmacytimes.com/view/suzetrigine-after-knee-replacement-are-fewer-opioid-prescriptions-enough-<![CDATA[William J. Peppard, PharmD, explains how emerging suzetrigine findings after knee arthroplasty connect opioid stewardship with functional recovery and the pharmacist’s role in ensuring treatment access.]]>Mon, 05 Oct 2026 20:26:53 GMTPharmacy TimesusPharmacy Times Articleshttps://www.pharmacytimes.com/view/expert-q-a-severe-pneumococcal-infection-may-signal-hidden-blood-cancer-or-immunodeficiencyhttps://www.pharmacytimes.com/view/expert-q-a-severe-pneumococcal-infection-may-signal-hidden-blood-cancer-or-immunodeficiency<![CDATA[Tor Härnqvist, MD, discusses immune testing after invasive pneumococcal disease, serotype-informed vaccine selection, and pharmacists' role in supporting patients on immunoglobulin therapy.]]>Mon, 05 Oct 2026 20:05:36 GMTPharmacy TimesusPharmacy Times Articleshttps://www.pharmacytimes.com/view/orforglipron-shows-cv-safety-vs-insulin-glargine-in-achieve-4https://www.pharmacytimes.com/view/orforglipron-shows-cv-safety-vs-insulin-glargine-in-achieve-4<![CDATA[In adults with type 2 diabetes at high cardiovascular (CV) risk, the oral GLP-1 RA also improved HbA1C and weight, with less hypoglycemia but more GI events.]]>Mon, 05 Oct 2026 18:47:07 GMTPharmacy TimesusPharmacy Times Articleshttps://www.pharmacytimes.com/view/butter-beef-tallow-and-ldl-where-dietary-guidelines-divergehttps://www.pharmacytimes.com/view/butter-beef-tallow-and-ldl-where-dietary-guidelines-diverge<![CDATA[An expert explains why plant-based cooking oils remain the NLA's recommendation for patients at cardiovascular risk, despite new federal advice. ]]>Mon, 05 Oct 2026 18:00:00 GMTPharmacy TimesusPharmacy Times Articleshttps://www.pharmacytimes.com/view/ncpa-presents-rep-buddy-carter-with-spirit-of-independence-awardhttps://www.pharmacytimes.com/view/ncpa-presents-rep-buddy-carter-with-spirit-of-independence-award<![CDATA[Rep. Buddy Carter (R-Ga.) has been named the NCPA’s 2026 Spirit of Independence Award recipient.]]>Mon, 05 Oct 2026 17:33:00 GMTPharmacy TimesusPharmacy Times Articleshttps://www.pharmacytimes.com/view/why-a-good-income-isn-t-enoughhttps://www.pharmacytimes.com/view/why-a-good-income-isn-t-enough<![CDATA[Tim Ulbrich, PharmD, explains why a strong income alone doesn't guarantee financial progress and outlines 3 levers that have an outsized impact on building long-term wealth.]]>Mon, 05 Oct 2026 16:59:37 GMTPharmacy TimesusPharmacy Times Articleshttps://www.pharmacytimes.com/view/could-linvoseltamab-change-when-we-treat-high-risk-smoldering-myeloma-https://www.pharmacytimes.com/view/could-linvoseltamab-change-when-we-treat-high-risk-smoldering-myeloma-<![CDATA[In an interview with Pharmacy Times, LINKER-SMM1 study investigator Paula Rodríguez-Otero, MD, PhD, a hematologist at Clínica Universidad de Navarra in Pamplona, Spain, explains how researchers selected high-risk patients and how she weighs infections against the potential to prevent progression to active disease.]]>Mon, 05 Oct 2026 16:08:04 GMTPharmacy TimesusPharmacy Times Articleshttps://www.pharmacytimes.com/view/precision-in-practice-biomarker-testing-and-treatment-selection-in-primary-advanced-or-recurrent-endometrial-cancerhttps://www.pharmacytimes.com/view/precision-in-practice-biomarker-testing-and-treatment-selection-in-primary-advanced-or-recurrent-endometrial-cancer<![CDATA[Sponsored by GSK NPUS-ECUCOCO260043 September 2026]]>Mon, 05 Oct 2026 13:00:00 GMTPharmacy TimesusPharmacy Times Articleshttps://www.pharmacytimes.com/view/pharmacists-key-to-lp-a-counseling-and-lipid-optimizationhttps://www.pharmacytimes.com/view/pharmacists-key-to-lp-a-counseling-and-lipid-optimization<![CDATA[Pharmacists can prompt once-in-a-lifetime Lp(a) testing, reinforce statin adherence, and put muscle aches in context, according to the NLA president. ]]>Sun, 04 Oct 2026 19:45:00 GMTPharmacy TimesusPharmacy Times Articleshttps://www.pharmacytimes.com/view/ncpa-releases-2026-digest-reporthttps://www.pharmacytimes.com/view/ncpa-releases-2026-digest-report<![CDATA[The 2026 NCPA Digest, sponsored by Cardinal Health, was released today as part of the NCPA’s Annual Convention, being held Oct. 3-6 in Kansas City.]]>Sun, 04 Oct 2026 17:46:00 GMTPharmacy TimesusPharmacy Times Articleshttps://www.pharmacytimes.com/view/t-j-woodard-named-2026-ncpa-willard-b-simmons-independent-pharmacist-of-the-yearhttps://www.pharmacytimes.com/view/t-j-woodard-named-2026-ncpa-willard-b-simmons-independent-pharmacist-of-the-year<![CDATA[NCPA is pleased to announce that T.J. Woodard, PharmD, owner of Prescriptions to Geaux, is the winner of the 2026 NCPA Willard B. Simmons Independent Pharmacist of the Year Award. ]]>Sun, 04 Oct 2026 17:45:00 GMTPharmacy TimesusPharmacy Times Articles